137 related articles for article (PubMed ID: 9612676)
1. Etiology and diagnosis of prostate cancer: what's new? A review.
Zlotta AR; Schulman CC
Eur Urol; 1998; 33(4):351-8. PubMed ID: 9612676
[No Abstract] [Full Text] [Related]
2. Prostate-specific antigen or human kallikrein 3? Recent developments.
Diamandis EP
Tumour Biol; 1998; 19(2):65-7; discussion 67-8. PubMed ID: 9486557
[No Abstract] [Full Text] [Related]
3. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
4. Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?
MartÃnez-Salamanca JI
Arch Esp Urol; 2012 Mar; 65(2):209-14. PubMed ID: 22414449
[No Abstract] [Full Text] [Related]
5. Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease.
Routh JC; Leibovich BC
Mayo Clin Proc; 2005 Jul; 80(7):899-907. PubMed ID: 16007895
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening practices and cancer control research (United States).
Schottenfeld D; Colditz GA
Cancer Causes Control; 2002 Feb; 13(1):1-5. PubMed ID: 11899113
[No Abstract] [Full Text] [Related]
7. [Prostate Specific Antigen (PSA), yet how much damage?].
Braillon A; Hill C; Dubois G
Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
[TBL] [Abstract][Full Text] [Related]
8. What's new in prostate cancer screening and prevention?
Klein EA
Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
[TBL] [Abstract][Full Text] [Related]
9. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
[TBL] [Abstract][Full Text] [Related]
10. Active surveillance for prostate cancer: a review.
Klotz L
Arch Esp Urol; 2011 Oct; 64(8):806-14. PubMed ID: 22052761
[TBL] [Abstract][Full Text] [Related]
11. Biopsy diagnosis of prostatic cancer--current areas of concern.
Feneley MR; Parkinson MC
J Clin Pathol; 1997 Apr; 50(4):265-6. PubMed ID: 9215135
[No Abstract] [Full Text] [Related]
12. Prostatic cancer.
Olsson C
Kidney Int; 1993 Apr; 43(4):955-65. PubMed ID: 7683069
[No Abstract] [Full Text] [Related]
13. Carcinoma of the prostate: overview of the most common malignancy in men.
Carson CC
N C Med J; 2006; 67(2):122-7. PubMed ID: 16752715
[No Abstract] [Full Text] [Related]
14. What's a doctor to do? Helping patients decide about prostate cancer screening.
Katz A; Sisler JJ
Can Fam Physician; 2004 Jan; 50():14-6, 22-4. PubMed ID: 14761096
[No Abstract] [Full Text] [Related]
15. Precursors of prostatic cancer: progression, regression and chemoprevention.
Montironi R; Schulman CC
Eur Urol; 1996; 30(2):133-7. PubMed ID: 8875193
[No Abstract] [Full Text] [Related]
16. A new approach to managing prostate cancer is essential.
Reynolds TM; Mitchell HD
Lancet Oncol; 2004 Apr; 5(4):205; discussion 205-6. PubMed ID: 15050948
[No Abstract] [Full Text] [Related]
17. Prostate cancer screening "reloaded".
Gomella LG
Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
[No Abstract] [Full Text] [Related]
18. Screening for prostate cancer.
Postma R; Schröder FH
Eur J Cancer; 2005 Apr; 41(6):825-33. PubMed ID: 15808952
[TBL] [Abstract][Full Text] [Related]
19. [Prostate, cancer and lost patients].
Nau JY
Rev Med Suisse; 2012 May; 8(343):1186-7. PubMed ID: 22737953
[No Abstract] [Full Text] [Related]
20. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association.
Cancer Registration Committee of the Japanese Urological Association
Int J Urol; 2005 Jan; 12(1):46-61. PubMed ID: 15661054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
